London, UK--(Marketwire - November 20, 2007) -

              SKYEPHARMA TO PRESENT AT PIPER JAFFRAY

                      2007 HEALTH CARE CONFERENCE

LONDON, UK, 20 November 2007-- SkyePharma PLC (LSE: SKP) announces today that the Company's Chief Executive Officer, Frank Condella, will make a presentation at the Piper Jaffray 2007 Health Care Conference in New York. Mr Condella will deliver his presentation on Tuesday 27 November 2007 at 3.00 p.m. EST (8.00 p.m. GMT). Investors may access a live webcast of the presentation at www.skyepharma.com under the Investor Relations tab. An archived version of the presentation will be available later that day.

For further information please contact:

SkyePharma PLC                       Frank Condella    +44 20 7491 1777
                                     Ken Cunningham
                                     Peter Grant

Financial Dynamics (UK Enquiries)    David Yates       +44 20 7831 3113
                                     Deborah Scott

Trout Group (US Enquiries)           Christine Labaree +1 617 583 1308
                                     Seth Lewis

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has eleven approved products in the areas of oral, inhalation and topical delivery that are marketed throughout the world by leading pharmaceutical companies.

For more information, visit www.skyepharma.com

                      This information is provided by RNS
            The company news service from the London Stock Exchange